Among the small bunch of billionaires that the local biotech industry has created, Tim Springer may be the only one who regularly rides his bike to work in the Longwood Medical Area, where his ID tag identifies him simply as a “staff scientist.”
Springer, a 74-year-old professor at Harvard Medical School and a research lab chief at Boston Children’s Hospital, is a heads-down scientist and entrepreneur with some notable quirks. He once commissioned a modern dance piece to explain the behavior of a kind of protein he studies called an integrin. He has shipped many tons of nature-sculpted “scholar rocks,” or gongshi, from China to his home in Newton, where they are displayed in his back yard. He says that during his freshman year at Yale in the mid-1960s, he rebelled against the requirement to wear a tie by putting one on over a t-shirt.
He’s also been a driving force behind some of the biggest companies in Boston biotech for the past 30 years.
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.
Already have an account? Log in
Already have an account? Log in
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect